# clm_9D9F1AD72987

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: total_equity  
value: 6,444,400,000 United States dollar  
valid_from: 2021-06-30  
valid_to: 2021-09-30  
published: 2021-08-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_B6A71BBF205E  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company total equity: 6,444,400,000 United States dollar", as of 2021-06-30 (until 2021-09-30). Claim clm_9D9F1AD72987, https://asof.is/claim/clm_9D9F1AD72987, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947821000171/0000059478-21-000171-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q2 FY2021, filed 2021-08-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947821000171/0000059478-21-000171-index.htm (primary, SEC EDGAR 10-Q Q2 FY2021, published 2021-08-03)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | total_equity | 6,898,700,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_9D9F1AD72987](/claim/clm_9D9F1AD72987.md) | [clm_FDEFFA86C333](/claim/clm_FDEFFA86C333.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.